SCHEMBL13600641

SCHEMBL13600641

CC(C)CCCCN1CCN(C(=O)c2ccco2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.64
▸ HTT P42858 2/20 0.62
▸ MAPT P10636 1/20 0.62
▸ ALOX15 P16050 1/20 0.62
▸ LMNA P02545 2/20 0.59
▸ CYP2D6 P10635 2/20 0.57
▸ PKM P14618 1/20 0.57
▸ KDM4E B2RXH2 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ TSHR P16473 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ HIF1A Q16665 1/20 0.56
▸ TP53 P04637 1/20 0.55
▸ NPSR1 Q6W5P4 2/20 0.54
▸ POLB P06746 1/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ KDM1A O60341 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13178363 0.86 ALDH1A1 (0.68) ALDH1A1HTTMAPTALOX15LMNA
SCHEMBL13472649 0.84 HTT (0.68) ALDH1A1HTTMAPTALOX15LMNA
SCHEMBL17207529 0.83 CYP2D6 (0.79) ALDH1A1HTTMAPTALOX15LMNA
SCHEMBL25223049 0.82 ALDH1A1 (0.67) ALDH1A1HTTMAPTALOX15LMNA
SCHEMBL12846701 0.81 HTT (0.71) ALDH1A1HTTMAPTALOX15PKM
SCHEMBL13600596 0.81 HTT (0.64) ALDH1A1HTTMAPTALOX15LMNA
SCHEMBL11788348 0.81 ALDH1A1 (0.68) ALDH1A1HTTMAPTALOX15LMNA
SCHEMBL9663935 0.80 HTT (0.69) ALDH1A1HTTMAPTALOX15PKM
Hydrochloric Acid SCHEMBL11788201 0.80 ALDH1A1 (0.67) ALDH1A1HTTMAPTALOX15LMNA
SCHEMBL9665396 0.79 HTT (0.67) ALDH1A1HTTMAPTALOX15PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632833-B2 Anticancer agents MERCK & CO., INC. (US) 2009-12-15 — — US disclosed
US-20080287414-A1 Mitotic Kinesin Inhibitors MERCK & CO., INC. (US) 2008-11-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287414-A1 Mitotic Kinesin Inhibitors KIF5B, KIF2C, KIF18B ALDH1A1 2057/4885HTT 1708/4885MAPT 234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback